IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 32.882
EU - Europa 31.809
NA - Nord America 19.590
SA - Sud America 10.394
AF - Africa 878
OC - Oceania 102
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 2
Totale 95.674
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 18.764
US - Stati Uniti d'America 18.660
SG - Singapore 12.571
CN - Cina 8.935
BR - Brasile 8.513
HK - Hong Kong 4.647
SE - Svezia 3.694
VN - Vietnam 3.468
IT - Italia 3.410
FR - Francia 1.803
DE - Germania 1.030
AR - Argentina 767
IN - India 639
GB - Regno Unito 574
FI - Finlandia 540
ID - Indonesia 459
CA - Canada 376
MX - Messico 350
BD - Bangladesh 349
NL - Olanda 323
EC - Ecuador 318
RO - Romania 286
IQ - Iraq 278
JP - Giappone 263
ZA - Sudafrica 261
IE - Irlanda 243
ES - Italia 238
TR - Turchia 227
CO - Colombia 223
PL - Polonia 186
AT - Austria 176
PY - Paraguay 149
PK - Pakistan 136
UA - Ucraina 129
CL - Cile 121
VE - Venezuela 119
MA - Marocco 113
UZ - Uzbekistan 94
EG - Egitto 93
SA - Arabia Saudita 92
PE - Perù 87
AU - Australia 80
TN - Tunisia 74
KE - Kenya 71
IR - Iran 63
PH - Filippine 63
NP - Nepal 62
AE - Emirati Arabi Uniti 56
LT - Lituania 56
UY - Uruguay 56
JO - Giordania 54
NG - Nigeria 54
DZ - Algeria 53
MY - Malesia 51
DO - Repubblica Dominicana 46
IL - Israele 42
AZ - Azerbaigian 37
KZ - Kazakistan 37
CH - Svizzera 34
AL - Albania 33
BE - Belgio 32
BO - Bolivia 30
GR - Grecia 29
BG - Bulgaria 28
LB - Libano 27
RS - Serbia 25
TW - Taiwan 25
PT - Portogallo 24
CZ - Repubblica Ceca 23
KR - Corea 22
TH - Thailandia 22
NO - Norvegia 21
OM - Oman 21
SN - Senegal 21
PA - Panama 20
BH - Bahrain 19
JM - Giamaica 18
TT - Trinidad e Tobago 18
BA - Bosnia-Erzegovina 17
HN - Honduras 17
TZ - Tanzania 17
KG - Kirghizistan 16
CR - Costa Rica 15
HU - Ungheria 15
PS - Palestinian Territory 15
GT - Guatemala 14
SV - El Salvador 14
AO - Angola 13
BY - Bielorussia 13
KH - Cambogia 13
KW - Kuwait 13
NZ - Nuova Zelanda 13
SY - Repubblica araba siriana 13
ET - Etiopia 12
BB - Barbados 11
NI - Nicaragua 11
XK - ???statistics.table.value.countryCode.XK??? 11
AM - Armenia 10
DK - Danimarca 10
GA - Gabon 10
Totale 95.444
Salva come PNG Salva come JPEG
Città #
Singapore 4.997
Hong Kong 4.598
Moscow 4.252
Dallas 4.110
San Jose 2.454
Ashburn 2.414
Shanghai 1.836
Hefei 1.802
Lawrence 1.712
Princeton 1.707
Lauterbourg 1.527
Ho Chi Minh City 1.298
Milan 768
Hanoi 724
Beijing 723
São Paulo 671
New York 596
Helsinki 412
Los Angeles 401
Rio de Janeiro 264
Dublin 234
Rome 231
Boardman 211
Nuremberg 193
Santa Clara 189
Orem 186
Munich 184
Belo Horizonte 182
Da Nang 166
Brasília 159
Warsaw 145
Tokyo 142
Brooklyn 139
Haiphong 137
Montreal 134
Guangzhou 130
Porto Alegre 126
Johannesburg 123
Chennai 120
Curitiba 120
Denver 109
Chicago 103
Frankfurt am Main 100
Quito 100
Guayaquil 98
Campinas 96
Salvador 96
Turin 96
Baghdad 94
Turku 93
Atlanta 90
Mexico City 89
Stockholm 88
Biên Hòa 87
Tianjin 85
Thái Bình 84
Tashkent 83
London 81
Guarulhos 80
Hải Dương 78
Poplar 78
Ribeirão Preto 78
Valencia 78
Amsterdam 76
Pune 76
Vienna 76
Houston 75
Naples 73
Toronto 73
Manaus 72
Manchester 71
Phoenix 71
Dhaka 69
Bologna 68
Mumbai 68
Washington 68
Council Bluffs 65
Florence 65
Jakarta 65
Seattle 65
Buenos Aires 64
Boston 62
Fortaleza 62
Hangzhou 62
Caxias do Sul 60
Lima 60
Paris 59
Goiânia 58
The Dalles 57
Bogotá 56
Erbil 54
Santo André 54
Nairobi 53
Cape Town 52
Ninh Bình 52
Recife 51
Istanbul 50
New Delhi 50
Asunción 48
Osasco 47
Totale 44.888
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.819
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.421
Benign Prostatic Hyperplasia and Its Aetiologies 456
Women's sexual dysfunction: a pathophysiological review 303
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 210
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 210
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 207
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 205
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 185
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 178
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 171
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 162
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 161
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 160
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 155
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 154
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 153
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 150
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 146
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 146
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 146
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 143
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 139
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 138
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 137
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 136
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 134
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 134
A propensity score approach for treatment evaluation based on Bayesian Networks 133
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 131
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 129
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 128
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 127
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 127
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 126
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 125
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 125
How to Select the Optimal Candidates for Renal Mass Biopsy 125
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 124
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 124
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 123
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 123
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 122
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 121
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 120
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 120
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 119
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 118
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 118
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 118
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 118
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 118
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 117
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 117
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 116
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 116
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 116
A risk calculator predicting recurrence in lymph node metastatic penile cancer 115
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 114
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 114
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 113
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 113
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 113
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 113
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis 112
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 112
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 112
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 112
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 111
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 110
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 110
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 110
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 110
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 110
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 110
Pelvic lymph node dissection in prostate cancer 109
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 109
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 109
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 108
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 108
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 108
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 108
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 108
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 107
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 107
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 107
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 107
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 107
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 106
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 106
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 106
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 106
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 105
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 105
Prediction of Sexual Function After Radical Prostatectomy 105
Totale 16.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 650.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 650.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 6 3 0
2021/20221.070 0 46 34 465 59 58 95 67 33 60 43 110
2022/20238.186 3.963 1.456 485 71 52 806 299 458 256 84 137 119
2023/20243.873 149 212 329 296 296 576 217 374 84 317 466 557
2024/202521.950 3.055 567 362 532 501 1.791 2.795 1.625 4.147 3.499 1.417 1.659
2025/202660.932 4.411 5.881 6.281 10.082 4.211 1.508 5.657 4.242 16.349 2.310 0 0
Totale 96.774